These data further demonstrate that the elaborated indole-2-carboxylic acid molecules described here are indeed cell-active MCL-1 inhibitors that behave as predicted in sensitizing cancer cells to the effects of BCL-2/BCL-XL inhibitors. This evidence concerns the gene BCL2L1 and cancer.